MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data

BACKGROUND: Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of these; also systematic reanalysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rana, Sharmila, Valbuena, Gabriel N., Curry, Ed, Bevan, Charlotte L., Keun, Hector C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810870/
https://www.ncbi.nlm.nih.gov/pubmed/35022525
http://dx.doi.org/10.1038/s41416-021-01677-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810870/
https://www.ncbi.nlm.nih.gov/pubmed/35022525
http://dx.doi.org/10.1038/s41416-021-01677-3

Ejemplares similares